CONNECT WITH US
HealthTech

HealthTech

Urgent action needed to safeguard the effectiveness of antibiotics

Medical Xpress logo

Published on

Add as a preferred source on Google
Urgent action needed to safeguard the effectiveness of antibiotics

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

With mounting evidence that antibiotic-resistant bacteria are continuing to spread and treatment options are becoming increasingly limited, urgent action is needed to safeguard the effectiveness of antibiotics, the European Center for Disease Prevention and Control (ECDC) said on the occasion of European Antibiotic Awareness Day.

"We are still behind with several of the EU's 2030 targets to counter antimicrobial resistance. However, the good news is that we can now look beyond just numbers," said ECDC Director Pamela Rendi-Wagner.

"Innovations such as faster genomic surveillance mean that we can now assess better and more rapidly how resistant bacteria spread and how they evade antibiotics. This in turn means we can act sooner to stop transmission, more effectively guide treatment decisions and identify where new antibiotics are most urgently needed."

ECDC coordinates three European networks collecting data on antimicrobial resistance and consumption. One specifically carries out genomic-based surveillance of multidrug-resistant bacteria and works to determine the geographical distribution and the genetic relatedness of multidrug-resistant clones, as well as the mechanisms of their resistance. This helps to improve risk assessment, guidance and treatment selection, and in this way enables countries to translate surveillance data into targeted public health action.

While increases in infections with resistant bacteria have been observed for many pathogens, certain bacteria are of particular concern due to their spread in health care facilities, their capacity to cause severe infections and their increased resistance to nearly all antibiotics.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.